Viewing Study NCT02628951


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-02-21 @ 7:15 PM
Study NCT ID: NCT02628951
Status: COMPLETED
Last Update Posted: 2020-11-19
First Post: 2015-12-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic Analysis
Sponsor: Samsung Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Adenocarcinoma View
None Gastroesophageal Junction Adenocarcinoma View
Keywords: